Overview
Standex International Q4 FY25 sales rise 23.2% yr/yr, beating analysts' expectations
Adjusted EPS for Q4 FY25 beats consensus, growing 20.6% yr/yr
Co paid down $27 mln debt, reducing net debt to EBITDA ratio to 2.6x
Outlook
Standex expects FY26 revenue to grow by over $100 mln
Company plans to release over 15 new products in FY26
Standex sees FY26 fast growth market sales exceeding $265 mln
Company anticipates FY26 adjusted operating margin expansion
Result Drivers
NEW PRODUCTS - Strong momentum from new products contributed to 23.2% sales increase in Q4 FY25
ACQUISITIONS - Acquisition of Amran/Narayan Group accelerated portfolio evolution, boosting adjusted operating margin and EPS
FAST GROWTH MARKETS - Sales in fast growth markets exceeded expectations, totaling $61 mln or 28% of total sales
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
Beat
$222 mln
$213.40 mln (4 Analysts)
Q4 Adjusted EPS
Beat
$2.28
$2.1 (5 Analysts)
Q4 EPS
$1.23
Q4 Adjusted EBITDA
Beat
$51.60 mln
$50.40 mln (4 Analysts)
Q4 Adjusted Operating Income
Beat
$45.80 mln
$42.50 mln (2 Analysts)
Q4 Adjusted EBIT Margin
20.6%
Q4 EBIT Margin
15.6%
Q4 Operating Income
$34.70 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the industrial machinery & equipment peer group is "buy"
Wall Street's median 12-month price target for Standex International Corp is $192.50, about 14.2% above its July 30 closing price of $165.12
The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 18 three months ago
Press Release: ID:nPn27NRXya
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)